The Patent Finder

Formulations of Bendamustine (2013)

Eagle Pharmaceuticals, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 10 of these applications claim priority to application 61/613,173, filed Mar 20, 2012. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 9,000,021Method of Treating Bendamustine-Responsive Conditions in Patients Requiring Reduced Volumes for Administration
In force
 · High confidence
Eagle Pharmaceuticals, Inc.In force
High confidence
US 9,034,908Formulations of Bendamustine
In force
 · High confidence
Eagle Pharmaceuticals, Inc.In force
High confidence
US 9,144,568Formulations of Bendamustine
In force
 · High confidence
Eagle Pharmaceuticals, Inc.In force
High confidence
US 9,572,887Formulations of Bendamustine
In force
 · High confidence
Eagle Pharmaceuticals, Inc.In force
High confidence
US 9,572,888Formulations of Bendamustine
In force
 · High confidence
Eagle Pharmaceuticals, Inc.In force
High confidence
US 9,579,384Method of Treating Bendamustine-Responsive Conditions in Patients Requiring Reduced Volumes for Administration
In force
 · High confidence
Eagle Pharmaceuticals, Inc.In force
High confidence
US 9,597,397Formulations of Bendamustine
In force
 · High confidence
Eagle Pharmaceuticals, Inc.In force
High confidence
US 9,597,398Formulations of Bendamustine
In force
 · High confidence
Eagle Pharmaceuticals, Inc.In force
High confidence
US 9,597,399Formulations of Bendamustine
In force
 · High confidence
Eagle Pharmaceuticals, Inc.In force
High confidence
US 10,052,385Formulations of Bendamustine
In force
 · High confidence
Eagle Pharmaceuticals, Inc.In force
High confidence
15 more patents in this group · Pro
10 of 25 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 25.
Upgrade to Pro
10 of these are in force and held by Eagle Pharmaceuticals, Inc..
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited